



























Biological	 prospecting,	 or	 ‘bioprospecting’,	 involves	 developing	 products	 from	 the	
compounds	obtained	from	living	organisms,	usually	with	commercial	gain	in	mind.	It	
is	a	controversial	 topic	 for	Areas	Beyond	National	 Jurisdiction	 (ABNJ)	mainly	due	to	
access	and	benefit	 sharing	 concerns.	 It	 is	 evident	 that	bioprospecting	 is	 growing	 in	
Antarctica	and	will	continue	to	do	so,	with	new	international	players	such	as	Malaysia	
joining	the	Antarctic	Treaty	who	have	commercial	interests	in	Antarctic	organisms.	Ex-
situ	 specimen	 repositories,	 such	as	 genome	databases,	 are	also	a	 growing	area	 for	
potential	bioprospectors,	with	new	techniques	being	developed	to	enable	effective	
screening	 of	 genomic	 information	 for	 novelty,	 allowing	 for	 the	 use	 by	 any	 party.	
Despite	 being	 a	 consistent	 topic	 at	 every	 Antarctic	 Treaty	 Consultative	 Meeting	




Convention	 on	 the	 Conservation	 of	 Antarctic	 Marine	 Living	 Resources	 (CCAMLR)	
regulate	 visits	 to	 Antarctica,	 including	 species	 harvesting	 and	 associated	
environmental	 effects,	 they	 are	 nonspecific	when	 it	 comes	 to	 deriving	 commercial	
profit	from	living	organisms	by	bioprospecting.	A	lack	of	clear	regulatory	measures	is	
partly	due	to	the	complexity	of	the	issue.	The	consensus-based	process	at	ATCMs	and	



























1 USEFUL DEFINITIONS 
	
ABNJ			 	 	 Areas	Beyond	National	Jurisdiction	
Antarctic	Treaty	Area			 The	area	south	of	60°	South	Latitude	
ASOC		 	 	 Antarctic	and	Southern	Ocean	Coalition	
ATS		 	 	 Antarctic	Treaty	Secretariat	
ATCM		 	 	 Antarctic	Treaty	Consultative	Meeting	
ATCP	 	 	 Antarctic	Treaty	Consultative	Party	








SCAR	 	 	 The	Scientific	Committee	on	Antarctic	Research	
UNCLOS	 	 United	Nations	Convention	on	the	Law	of	the	Sea	





extreme	 conditions,	 many	 of	 them	 the	 result	 of	 biochemical	 processes.	 As	 a	 result,	
Antarctica	is	considered	a	global	hot	spot	for	biological	prospecting	or	‘bioprospecting’,	
which	involves	developing	products	from	the	compounds	obtained	from	living	organisms.	
Bioprospecting	 often	 goes	 hand-in-hand	 with	 scientific	 research	 being	 undertaken	 on	
Antarctic	organisms,	and	research	funding	can	reflect	this	due	to	the	potential	commercial	
gain	 (Hughes	and	Bridge,	2010).	Examples	of	bioprospecting	 in	Antarctica	over	 several	
decades	 are	widespread	 and	 examples	 can	 be	 found	 in	 every	 biological	 kingdom,	 and	
aside	from	krill,	bacterial	species	are	the	most	widely	studied,	possibly	due	to	the	ease	of	
sample	collection	and	culture,	range	of	diversity,	and	the	variety	of	extremophile	traits	
they	 can	 exhibit.	 A	 recent	 study	 looked	 at	 recent	 proportions	 of	 patents	 per	 species	
grouping	between	2011-2014,	and	found	that	during	this	period	nearly	half	(42%)	of	all	
patents	relate	to	krill,	with	another	large	proportion	to	microorganisms	(19%),	yeasts	and	








Bioprospecting	 has	 traditionally	 been	 carried	 out	 via	 the	 collection	 of	 samples,	
identification	of	desirable	phenotypic	 traits,	 and	 the	 identification	and	 isolation	of	 the	
genes	that	code	them	(Slobodian	et	al.,	2015).	Compounds	can	then	be	reproduced	in	a	
laboratory,	patented,	and	turned	into	products.	Globally,	genetic	resources	are	used	to	
derive	 products	 for	 the	 pharmaceutical,	 biotechnology,	 agricultural,	 personal	 care,	
botanical	 and	 food	 and	 beverage	 sectors	 (Grieber	 et	 al.,	 2012).	 On	 one	 hand,	




2010).	 Following	 this	 view,	 product	 discovery	 and	 gaining	 exclusive	 rights	 through	
patenting	 could	 theoretically	 be	 seen	 as	 a	 financial	 return	 on	 investing	 in	 Antarctic	
science.	
	
In	 recent	 times	 genomic	 databases	 and	 ex	 situ	 samples	 have	 reduced	 the	 need	 for	
researchers	to	travel	to	Antarctica	to	collect	specimen	(ATCM,	2010;	Dong-Ha	Oh	et	al.,	
2012;	 Nur	 Athirah	 et	 al.,	 2015).	 For	 example,	 genetic	 databases	 can	 now	 be	 used	 by	
anyone	from	afar	to	search	species	genetic	codes	without	setting	foot	in	the	Antarctic,	
raising	 potential	 access	 and	 benefit	 sharing	 issues.	 Given	 the	 cost	 associated	 with	
conducting	specimen-collection	in	the	Antarctic,	this	could	be	seen	as	a	cheap	method	of	
prospecting	genetic	resources.	It	could	also	be	seen	as	a	non-invasive	way	(in	the	sense	




areas	and	 is	vague	as	 to	which	 international	measures	 regulate	commercial	 interest	 in	
Antarctic	 species.	 This	 report	 will	 evaluate	 the	 current	 regulatory	 measures	 in	 the	





3 THE FUTURE OF BIOPROSPECTING IN ANTARCTICA 
	















followed	 by	 that	 of	 microorganisms	 (Figure	 2).	 Pharmaceuticals	 is	 the	 main	 industry	
benefiting	 from	 the	 use	 of	 Antarctic-derived	 products.	 Some	 recent	 examples	 include	
potential	cancer	therapies	from	microorganisms	found	in	the	lake	East	Antarctic	Dronning	
Maud	 Land,	 fungi	 with	 anti-inflammatory	 compounds	 and	 lichens	 with	 antibiotic	
properties	from	King	George	Island	(ATCM,	2015).	Patents	relating	to	krill	have	included	



































































































3.1 KEY PLAYERS OPERATING IN ANTARCTICA 
	
The	 Antarctic	 Treaty	 has	 been	 described	 as	 an	 ‘elitist	 club’	 with	 the	 key	 players	
traditionally	being	post-Cold	War	countries	such	as	the	United	States,	United	Kingdom,	
Russia	 and	Australia	 (Brady,	2013;	Hemmings,	2014).	However,	 a	new	 ‘global	order’	 is	
forming	 in	 Antarctica,	with	 rising	 interests	 of	 Asian	 countries	 such	 as	Malaysia,	 China,	





Kazakhstan,	 Belarus,	 Iceland,	 Portugal	 and	 Venezuela,	 many	 of	 which	 are	 old	 Soviet	
nations.	The	emergence	of	new	players	 in	the	ATS,	who	may	have	different	values	and	




dramatically,	 and	 became	 a	 signatory	 to	 the	 Treaty	 and	 declared	 their	 interest	 in	
becoming	a	full	consultative	party.	In	2016,	Malaysia	ratified	the	Madrid	Protocol	(New	
Strait	 Times,	 2016),	 which	 is	 another	 step	 towards	 this	 status.	 Malaysia	 has	 been	
progressively	implementing	new	national	policies	relating	to	science	and	technology	and	
has	been	open	about	their	economic	interest	in	Antarctica.	In	2005	a	Biotechnology	Policy	










of	 krill	 from	 Antarctica,	 and	 have	 had	 substantial	 commercial	 interest	 in	 krill	 related	
products	(Future	Oceans,	2016).	It	is	likely	that	the	trend	in	krill	products	will	continue	in	
the	future.	
4 INTERNATIONAL REGULATORY MEASURES 
	
The	Antarctic	Treaty	 (1959)	 sets	ethical	 standards	 for	bioprospecting	 in	 the	sense	 that	
Antarctica	is	set	aside	as	an	area	for	peace,	science	and	free	information-sharing.	However	





Grieber,	 2011).	 In	 addition	 to	 this,	 because	 of	 the	 variety	 of	 steps	 involved	 in	
bioprospecting,	 from	 the	 collection	 of	 samples	 right	 through	 to	 the	 development	 of	
commercial	 products,	 this	 has	 it	 difficult	 to	 define	 the	 parameters	 of	 the	 term	








of	 the	 bioprospecting	 industry.	 The	 Protocol	 for	 Environmental	 Protection	 or	 “Madrid	
Protocol”	and	the	Convention	on	the	Conservation	of	Antarctic	Marine	Living	Resources	






Antarctic	 Treaty	 area.	 These	 claims	 have	 remained	 ‘frozen’	 and	 unresolved	 since	 the	




4.1 THE CONVENTION ON BIOLOGICAL DIVERSITY 
	
Oldham	 et	 al.	 (2013)	 identified	 three	 key	 principles	 which	 international	 debates	 on	





on).	 The	 second	 principle	 of	 equitable	 benefit	 sharing	 states	 that	 those	 providing	 the	
genetic	 resources	 and	 traditional	 knowledge	 obtain	 benefits	 from	 the	 sharing	 of	 their	
knowledge	 with	 other	 users.	 The	 third	 principle	 is	 to	 promote	 fair	 access	 to	 genetic	
resources	in	order	to	foster	research	and	development.	These	principles	have	relevance	


















financial	mechanism	 exists	 under	 the	 CBD	 for	 contracting	 parties	 to	 give	 ‘developing’	
contracting	 parties,	 who	may	 be	 at	 a	 financial	 disadvantage,	 the	 ability	 to	 implement	
essential	elements	of	the	CBD.	To	supplement	the	CBD,	the	Nagoya	Protocol	entered	into	
force	in	2014	with	the	aim	of	providing	a	legal	framework	for	fair	and	equitable	sharing	of	






traditional	 knowledge	and	biological	 resources	 (Oldham	et	al.,	 2013).	 Importantly,	 this	









4.2 THE UNITED NATIONS CONVENTION ON THE LAW OF THE SEA 
	
The	UNCLOS,	which	entered	into	force	 in	1994,	 is	a	comprehensive	 legal	regime	which	
establishes	governance	over	the	use	and	resource	exploitation	of	the	world’s	oceans	and	
seas.	The	UNCLOS	recognises	ownership	rights	over	the	seas,	which	extend	out	a	fixed	






applicable	 to	 the	Antarctica,	which	 is,	 for	 the	most	 part,	 regarded	 as	 an	 ABNJ.	 This	 is	
somewhat	complicated	by	the	frozen	sovereignty	claims	over	parts	of	Antarctica	which	












UNCLOS	 (beneath	 the	 ocean	 floor	 subsoil).	 This	 could	 be	 seen	 as	 another	 gap	 in	 the	
legislation.	
	






genetic	 resources,	 as	 it	 requires	 information	 on	 scientific	 programmes	 and	 their	
objectives	 and	 knowledge	 from	 marine	 scientific	 research	 to	 be	 published	 and	
disseminated,	along	with	promoting	data	and	information	flow	(especially	to	developing	








4.3 THE MADRID PROTOCOL 
	
The	Madrid	Protocol	was	ratified	in	1998	by	the	Treaty	Parties.	The	Protocol	sets	out	the	






Antarctic.	 Under	 Article	 8.1	 this	 includes	 any	 activity	 “pursuant	 to	 scientific	
research	 programmes,	 tourism	 and	 all	 other	 governmental	 and	 non-
governmental	activities	in	the	Antarctic	Treaty	area”.	In	summary,	if	the	activity	
is	 initially	 assessed	 as	 having	 a	 “less	 than	 minor	 or	 transitory	 impact”	 it	 can	
proceed	without	an	assessment,	while	those	with	a	“minor	or	transitory	impact”	
undergo	a	permitting	process	under	national	regulations,	and	those	likely	to	have	
a	 “more	 than	 minor	 or	 transitory”	 impact	 require	 a	 Comprehensive	
Environmental	 Evaluation	 (CEE),	 which	 is	 forwarded	 to	 all	 Treaty	 parties	 for	
comment	and	a	final	decision.		
• Article	 3.1	 which	 aims	 to	 protect	 the	 Antarctic	 environment,	 including	 the	
intrinsic	values	of	Antarctica.	It	also	states	that	“activities	shall	be	planned	and	
conducted	 in	 the	 Antarctic	 Treaty	 area	 so	 as	 to	 accord	 priority	 to	 scientific	
research	and	to	preserve	the	value	of	Antarctica	as	an	area	for	the	conduct	of	




















parties	on	any	given	year	had	 submitted	a	 report.	 This	demonstrates	 that	 information	









4.4 THE CONVENTION ON THE CONSERVATION OF ANTARCTIC MARINE LIVING 
RESOURCES 
	
The	 CCAMLR	 was	 ratified	 in	 1982	 by	 the	 Treaty	 Parties	 with	 the	 aim	 of	 conserving	




precise	 lines,	 so	 that	 the	 Convention	 area	 is	 easily	 understood).	 The	 aspects	 of	 the	
Convention	with	relevance	to	bioprospecting	include:	
	
• Article	 II	which	 sets	out	 that	 ‘conservation’	of	marine	 living	 resources	 includes	
‘rational	use’.	Any	harvesting	and	associated	activities	have	to	align	with	 three	






and	 other	 data	 and	 information	 annually	 to	 the	 Treaty	 parties	 and	 Scientific	




4.5 ANTARCTIC TREATY CONSULTATIVE MEETINGS 
	
Bioprospecting	 has	 been	 a	 consistent	 topic	 at	 Antarctic	 Treaty	 Consultative	Meetings	
(ATCMs)	since	2002	when	concerns	were	put	forward	by	the	United	Kingdom	about	the	
regulation	 of	 bioprospecting	 under	 the	 ATS	 (ATCM,	 2002).	 In	 2005	 Resolution	 7	 was	
agreed	 to	 at	 the	 Antarctic	 Treaty	 Consultative	 Meeting	 (ATCM)	 in	 Stockholm	 which	
encouraged	 the	 Antarctic	 Treaty	 information	 sharing	 principles	 of	 Article	 III(1)	 to	 be	
upheld.	 It	 also	 encouraged	 parties	 to	 ‘keep	 under	 review	 the	 question	 of	 biological	
prospecting’	 and	 to	 exchange	 information	 on	 an	 annual	 basis	 relating	 to	 the	 topic	 as	
appropriate.	As	the	result	of	much	discussion	and	concern	around	whether	the	ATS	was	
appropriate	for	the	management	of	bioprospecting,	another	resolution	was	agreed	to	in	
2009,	 which	 reaffirmed	 that	 the	 Antarctic	 Treaty	 and	 associated	 measures	 (Madrid	




working	 definition	 of	 the	 term	 is	 a	 consideration.	 This	 resolution	 again	 encouraged	
consultative	 parties	 to	 report	 on	 bioprospecting	 activities	 carried	 out	 under	 their	












to	allow	searchable	 to	up	 to	date	bioprospecting	 information	on	 research	and	
commercial	products	(ATCM,	2008).	Recent	attempts	to	access	this	website	(as	











from	 small	 university	 laboratories	 and	 national	 public	 collections	 to	 large	
commercial	 collections”,	 and	 that	 while	 they	 are	 important	 for	 biodiversity	
conservation,	 research	 and	 development,	 they	 can	 complicate	 the	 matter	 of	






















emphasising	 that	 further	 measures	 are	 urgently	 needed.	 Slow	 progress	 on	 complex	













or	 that	 the	 issues	 should	 left	 for	 the	 next	 meeting	 (ATCM,	 2014a).	 There	 were	 also	

























policy	 to	 take	 shape.	 Some	 of	 these	 international	 discussions	 include:	 The	
operationalisation	of	the	Nagoya	Protocol,	discussions	at	the	Ad-hoc	Open	Ended	Informal	
Working	Group	on	conservation	and	sustainable	use	of	marine	resources	in	ABNJ	(hereby	









4.6 PATENTING AND INFORMATION SHARING 
		
Patenting	of	a	product,	or	establishing	exclusive	legal	rights,	is	often	seen	as	the	end	result	
of	 bioprospecting.	 At	 this	 stage,	 the	 biological	 resources	 in	 Antarctica	 are	 open	 to	
patenting,	 which	 includes	 “biochemicals,	 genes,	 proteins	 and	 micro-organisms	 […]	
provided	 that	 the	 invention	 in	 question	meets	 the	 general	 patent	 criteria	 of	 novelty,	
inventiveness	and	 industrial	 application”	 (Tvedt,	2011).	Genetic	 resources	 can	become	











access,	 freeing	up	more	 funds	 for	 further	prospecting.	A	 key	 issue	with	patenting	 in	 a	
‘global	commons’	situation	is	that	scientific	data	and	results	are	kept	secret	until	they	are	
published.	Patenting	therefore	raises	questions	about	freedom	of	information	and	the	use	
of	 resources,	 especially	 with	 the	 ATS	 information-sharing	 principles	 in	 mind.	 SCAR	 in	














This	 raises	 questions	 over	 where	 patenting	 rights	 lie	 with	 commercial	 operations	
operating	 alongside	 with	 national	 science	 programmes	 (Hughes	 and	 Bridge,	 2010).	
Presumably,	national	science	programmes,	and	Antarctic	scientists	in	general,	would	want	





4.7 EX SITU PROSPECTING 
	
The	 issue	 of	 ex-situ	 collections	was	 first	 examined	 in	 an	 Antarctic	 Treaty	 Consultative	
Meeting	in	2010	by	the	UNEP	and	Belgium	(ATCM,	2010a).	This	paper	noted	that	a	variety	
of	Antarctic	genetic	and	specimen	collections	exist	in	different	forms,	such	as	gene	banks,	
museums	 and	 private	 scientific	 collections.	 Genomic	 resources	 in	 particular	 are	 freely	
available	for	many	Antarctic	species	as	a	result	of	the	Antarctic	Treaty	System	information	
sharing	principles:	GenBank,	 for	 example,	 lists	 full	 genomes	and	nucleotide	 sequences	
from	a	range	of	Antarctic	species	(NCBI,	2017).	These	repositories	are	useful	for	providing	
research	material	without	making	a	costly	trip	to	the	Antarctic,	and	the	benefit	of	their	
use	 is	 that	 direct	 environmental	 effects	 to	 Antarctica	 from	 specimen	 collection	 is	
prevented.	 As	 genomic	 resources	 grow,	 so	 too	 do	 innovative	 methods	 of	 screening	





The	UNEP	 and	Belgium	have	noted	 that:	 “In	 some	 cases	where	ex	 situ	 collections	 are	
vectors	for	commercial	use,	it	can	be	difficult	to	trace	the	lineage	of	a	particular	organism	
or	strain	from	its	source	to	a	patent	or	product.	This	is	particularly	true	for	bacteria	and	













by	 the	 World	 Federation	 of	 Culture	 Collections	 and	 the	 World	 Data	 Centre	 for	
Microorganisms	for	microbial	strains	and	species	(ATCM,	2015),	enabling	the	tracking	of	
their	utilisation,	although	it	is	unclear	whether	this	measure	will	apply	to	Antarctic	species.	






5 DISCUSSION AND RECOMMENDATIONS 
	
With	 economic	 interest	 in	 Antarctic	 organisms	 set	 to	 continue	 into	 the	 future	 it	 is	
important	that	ATCPs	try	and	agree	upon	ways	in	which	bioprospecting	will	be	regulated	























of	 information.	 Commercialisation	 and	 patenting	 are	 opposing	 forces	 to	 information	
sharing.	 Article	 III	 of	 the	 Treaty	 promotes	 international	 cooperation	 and	 information-
sharing	from	scientific	operations,	and	provides	that	scientific	observations	and	results	
from	Antarctica	should	be	made	freely	available.	Arguably,	bioprospecting	is	an	extension	











behind	 areas	 with	 national	 jurisdiction	 as	 its	 resources	 can	 be	 prospected	 freely	 by	
commercial	 enterprises	 without	 any	 repercussions.	 Because	 resources	 are	 free	 from	






























be	 set	 by	 ATCPs	 to	 agree	 on	 the	 development	 of	 a	 comprehensive	 regulatory	
measure	for	bioprospecting,	with	a	dedicated	working	group	established	for	this	
purpose.	 This	 could	 address	 definitions,	 timeframes	 for	 results	 publication,	
tweaking	 the	 legal	 instrument	 (Madrid	 Protocol	 or	 CCAMLR)	 which	




monetary	 benefits	 derived	 from	 bioprospecting	 activities.	 There	 are	 plenty	 of	
examples	that	 this	 idea	could	be	modelled	off,	 such	as	 those	set	up	under	 the	
CBD,	 Convention	 on	 the	 Regulation	 of	 Antarctic	 Mineral	 Resource	 Activity	








purpose	 in	 improving	 the	 system	 if	 parties	 do	 not	 currently	 submit	 any	





















growing	 industry.	 The	 fact	 that	 bioprospecting	 does	 not	 currently	 align	 with	 core	
components	 of	 the	 Antarctic	 Treaty	 on	 information	 sharing	 makes	 this	 even	 more	
pressing.	Key	 recommendations	made	 in	 this	 report	 include	 the	creation	of	 temporary	
bioprospecting	best	practice	‘guidelines’	for	parties,	setting	strict	deadlines	for	revisiting	
regulatory	 discussions	 and	 coming	 to	 an	 agreement,	 reinstating	 the	 Bioprospector	





(and	 therefore	 bioprospecting)	 in	 their	 national	 science	 plans.	 One	 growing	 industry	
which	 is	 likely	 to	become	more	prevalent	 in	 the	 future	 is	 genomic	database	mining	of	
freely	accessible	data	from	ABNJ,	which	poses	an	 interesting	question	for	 international	
law	in	general.	
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